Tag: Aurobindo Pharma

Aurobindo Pharma announced that the United States Food and Drug Administration (USFDA) has issued Form 483 with 10 observations after the inspection...

New Delhi: Aurobindo Pharma Ltd. said it has received an Establishment Inspection Report (EIR) from the US health regulator for its manufacturing facility at Pydibhimavaram in...

Aurobindo Pharma units are recalling different products in the US market for manufacturing lapses, as per the US health regulator.

Drugs recall Leading drug firms like Dr. Reddy's Laboratories, Cipla, and Aurobindo Pharma are recalling different products in the US market for...

Aurobindo Pharma said the US health regulator has issued Form 483 with three observations after inspecting its manufacturing facility at Pydibhimavaram in...

New Delhi: Aurobindo Pharma Ltd on Wednesday said its arm, Eugia Pharma Specialities Ltd, has received final approval from the US health regulator to manufacture and...

The pre-approval inspection of Aurobindo Pharma was carried out from 8 February 2022 to 15 February 2022. On completion of the inspection,...

Zudus Zydus Lifesciences has received final approval from the US Food and Drug Administration (USFDA) to market Bortezomib...

New Delhi: The US Food and Drug Administration (USFDA) has issued a warning letter to Aurobindo Pharma for violating current good manufacturing practice norms...

Aurobindo Pharma yesterday said it has received a warning letter from the US health regulator for its Hyderabad-based Unit I, an Active...

Two Indian pharmaceutical companies have sought permission from India’s drug regulator to continue phase III trials on antiviral drug molnupiravir in mild C-19 patient....

Glenmark Pharmaceuticals and Aurobindo Pharma are recalling multiple products in the US market due to various reasons like deviation from standard manufacturing protocols and presence of foreign...

The Indian Patent Office has granted patent to Aurobindo Pharma for its process for the preparation of its antiviral drug valacyclovir, which...

New Delhi: Drug firm Aurobindo Pharma on Friday said its arm Eugia Pharma Specialities has received approval from the US health regulator for Cyclophosphamide injection, used in...

The Department of Pharmaceuticals (DoP) has re-invited applications from eligible applicants to manufacture fermentation based key starting material/drug intermediate erythromycin thiocyanate under...

Sun Pharma, Dr Reddy’s Laboratories, Aurobindo Pharma and Jubilant Pharma are recalling products in the US market for various reasons.

New Delhi: Drug major Aurobindo Pharma on Friday said it has received final approval from the US health regulator to manufacture and market Droxidopa capsules, used...

The government plans to select more pharmaceutical firms for its production-linked incentive (PLI) scheme for 37 bulk drugs by the end of...

Aurobindo Pharma Ltd said on Thursday that it will make COVAXX's C-19 vaccine candidate for India and UNICEF under a licensing deal....

HYDERABAD: Pfizer Inc and its group companies filed a petition in a US court against Aurobindo Pharma Ltd and Dr Reddy's Laboratories alleging that the Indian drug...

New Delhi: Indian drug firms like Marksans Pharma, Aurobindo Pharma, Zydus and Jubilant are recalling products in the US market, as per the latest enforcement report by the...

New Delhi: Drug firm Aurobindo Pharma on Thursday said it has received final approval from the US health regulator for its generic Acetaminophen injection, used...

Aurobindo Pharma has entered into a share purchase agreement today to acquire 100 per cent equity share capital of MViyeS Pharma Ventures....

Hyderabad: The US Food and Drug Administration (FDA) has issued a 'Form 483' with nine observations to a manufacturing facility in the...